2. Signaling Pathways
  3. Immunology/Inflammation
  4. ALCAM/CD166
  5. ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-P99788
    Praluzatamab
    		Inhibitor 99.98%
    Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
  • HY-P991532
    AT002
    		Inhibitor
    AT002 (CBAS-173, EJ212/007-Cl2-5) is a recombinant human IgG1 monoclonal antibody. AT002 targets the cell surface protein activated leukocyte adhesion molecule (ALCAM)/CD166. AT002 can be used in the research of cancer, autoimmune diseases and inflammatory diseases.